ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart failure"

  • 2022 American Transplant Congress

    Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation

    V. Subramanian1, K. Bowers2, H. Kalagotla2, J. Buggs1, N. Kemmer1, K. Dhanireddy1

    1Transplant Institute, Tampa General Hospital, Tampa, FL, 2University of South Florida, Tampa, FL

    *Purpose: Cardiovascular complications after liver transplantation (LTx) are a leading cause of morbidity and mortality. The goal of this study was to evaluate risk factors…
  • 2022 American Transplant Congress

    Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis

    C. J. Rosenthal1, D. Noguchi1, J. A. Aboulhosn2, G. S. Van Arsdell3, A. Nsair4, M. Ha1, L. Reardon2, G. Lluri4, J. P. Lin4, S. Saab1, A. Baird1, R. S. Venick1, D. G. Farmer1, F. M. Kaldas1

    1Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA, 2Ahmanson/UCLA Adult Congenital Heart Disease Center, UCLA, Los Angeles, CA, 3Cardiac Surgery, UCLA, Los Angeles, CA, 4Cardiology, UCLA, Los Angeles, CA

    *Purpose: The rate of combined heart-liver transplantation (HLT) has tripled in the last decade, and continues to rise along with the number of patients with…
  • 2022 American Transplant Congress

    Ventricular Modeling Following Bariatric Surgery Decreases Need for Heart Transplantation

    R. Choudhury1, A. Rouhi2, G. Hoeltzel3, Y. Bababekov1, A. Suarez-Pierre4, A. Yule1, N. Vigneshwar4, N. Williams5, K. Dumon2, T. Nydam1

    1Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 3General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, 4Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, 5General Surgery, Hospital of the University of Pennsylvania, Aurora, CO

    *Purpose: For obese patients with congestive heart failure (CHF), aggressive weight loss has been associated with ventricular remodeling. Many have suggested offering bariatric surgery for…
  • 2022 American Transplant Congress

    Direct Central Ambulatory Venoarterial Extracorporeal Membrane Oxygenation and Double Lung Transplantation without Graft Reduction with Extreme Mediastinal Shift

    A. Gorton1, S. Keshavamurthy2

    1Cardiothoracic Surgery, University of Kentucky, Lexington, KY, 2University of Kentucky, Lexington, KY

    *Purpose: Double Lung transplantation in the presence of extreme mediastinal shift can be technically challenging due to donor sizing and recipient factors.*Methods: We present the…
  • 2022 American Transplant Congress

    Allogenic Cardiac Progenitor Cells Transplantation with Immune Suppressant Cyclosporine a Recovers Myocardial Infarction in Rodent Model

    M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, L. Chen, S. Guru, A. Stefanowicz, A. Bilewska, S. Zarinebaf, G. Zhi-Dong, S. Kaushal

    Pediatrics, Lurie Childrens Hospital, Chicago, IL

    *Purpose: Cardiac progenitor cells (CPCs) are well-characterized stem cell type shown to potentiate cardiac regeneration in myocardial infarct (MI) model. However, auto and allo immune…
  • 2022 American Transplant Congress

    Cd47 Expression on Transplanted Human Neonatal Mesenchymal Stem Cells Inhibits Phagocytosis in Rat Myocardial Infarction Model

    M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, L. Chen, S. Guru, A. Stefanowicz, A. Bilewska, S. Zarinebaf, G. Zhi-Dong, S. Kaushal

    Lurie Childrens Hospital, Chicago, IL

    *Purpose: Immune rejection of transplanted stem/progenitor cells is a major stumbling block in designing effective therapy for myocardial infarction (MI). Human neonatal mesenchymal stem cells…
  • 2021 American Transplant Congress

    Geographic Variation in Candidate Listing Behavior Under the New Heart Allocation Policy

    G. Ran1, K. Chung1, A. S. Anderson2, R. Gibbons3, N. Narang4, M. Churpek5, W. F. Parker1

    1Pritzker School of Medicine, University of Chicago, Chicago, IL, 2Department of Medicine, University of Texas San Antonio, San Antoion, TX, 3Department of Medicine, University of Chicago, Chicago, IL, 4Department of Medicine, University of Illinois-Chicago, Chicago, IL, 5Department of Medicine, University of Wisconsin, Madison, WI

    *Purpose: Describe and explain variations in listing practice among U.S. transplant centers in response to the new allocation policy.*Methods: We performed an observational cohort study…
  • 2021 American Transplant Congress

    Simultaneous Heart-Liver-Kidney Transplantation Survival: National and Single-Center Outcomes

    U. A. Siddiqi1, P. S. Combs1, G. Kim2, T. Baker3, Y. Becker1, V. Jeevanandam1

    1Section of Cardiac Surgery, University of Chicago Medicine, Chicago, IL, 2Section of Cardiology, University of Chicago Medicine, Chicago, IL, 3University of Chicago Medicine, Chicago, IL

    *Purpose: Simultaneous Heart-Liver-Kidney transplantation (SHLKTx) is an incredibly rare, high-risk operation undergone by well-selected patients presenting with multi-organ failure. Our center has performed 10 of…
  • 2021 American Transplant Congress

    An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report

    W. Hoffman, M. Waybill, H. Yang, D. Ladie, M. Singh

    UPMC Pinnacle Transplant, Harrisburg, PA

    *Purpose: ATTR-CM is underrecognized and commonly overlooked and undiagnosed. When found it is often a late diagnosis in patients with severe left ventricular hypertrophy (LVH)…
  • 2021 American Transplant Congress

    The Seattle Heart Failure Model is a Predictor of Mortality After Kidney Transplant in Patients with End Stage Renal Disease and Heart Impairment

    A. Perez-Gutierrez1, P. J. Bachul2, D. N. Danz3, B. Juengel2, M. Josephson2, J. Fung2, P. Witkowski2, B. Chung4, Y. Becker2

    1Surgery, University of Chicago, Chicago, IL, IL, 2Surgery, University of Chicago, Chicago, IL, 3Economics, University of Pittsburgh, Pittsburgh, IL, 4Cardiology, University of Chicago, Chicago, IL

    *Purpose: Cardiovascular disease is the main cause of mortality after kidney transplantation. Many patients with ESRD have heart failure that is attributed to fluid overload.…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences